Musk’s subsidiary granted approval to implant a chip in a human brain
Musk’s subsidiary granted approval to implant a chip in a human brain
Musk’s subsidiary granted approval to implant a chip in a human brain
The company, “Neuralink”, owned by US billionaire Elon Musk, said that it had obtained approval from the US Food and Drug Administration to start the first clinical trial to implant microchips in human brains, with the aim of treating incurable diseases such as paralysis and blindness.
The company added that this is the result of the great work that the “Neuralink” team has done in close cooperation with the US Food and Drug Administration, and represents an important first step that will allow our technology one day to help many more people.
Neuralink says that it aims, through the chip and the technology that works on it, to help people who suffer from paralysis, in order to restore movement in the best case or control computers and mobile phones to live independently.
It is noteworthy that Musk had previously expected, on at least 4 occasions since 2019, that Neuralink, which was founded in 2016, would obtain the necessary approvals to start human trials of his electronic chip. However, the US Food and Drug Administration announced last March its refusal to grant the company such approval.
The Food and Drug Administration attributed the reasons for its refusal to grant approval in the past to the existence of concerns that include the danger of the built-in lithium battery, as it stressed the need to conduct animal tests to prove that the battery is not subject to malfunction and cannot damage brain tissue.
